EuroSCORE II and STS as mortality predictors in patients undergoing TAVI
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista da Associação Médica Brasileira (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016000100032 |
Resumo: | SUMMARY Introduction: the EuroSCORE II and STS are the most used scores for surgical risk stratification and indication of transcatheter aortic valve implantation (TAVI). However, its role as a tool for mortality prediction in patients undergoing TAVI is still unclear. Objective: to evaluate the performance of the EuroSCORE II and STS as predictors of in-hospital and 30-day mortality in patients undergoing TAVI. Methods: we included 59 symptomatic patients with severe aortic stenosis that underwent TAVI between 2010 and 2014. The variables were analyzed using Student's t-test and Fisher's exact test and the discriminative power was evaluated using receiver operating characteristic curve (ROC) and area under the curve (AUC) with a 95% confidence interval. Results: mean age was 81±7.3 years, 42.3% men. The mean EuroSCORE II was 7.6±7.3 % and STS was 20.7±10.3%. Transfemoral procedure was performed in 88.13%, transapical in 3.38% and transaortic in 8.47%. In-hospital mortality was 10.1% and 30-day mortality was 13.5%. Patients who died had EuroSCORE II and STS higher than the survivors (33.7±16.7vs. 18.6±7.3% p=0,0001 for STS and 13.9±16.1 vs. 4.8±3.8% p=0.0007 for EuroSCORE II). The STS showed an AUC of 0.81 and the EuroSCORE II of 0.77 and there were no differences in the discrimination ability using ROC curves (p=0.72). Conclusion: in this cohort, the STS and EuroSCORE II were predictors of in-hospital and 30-days mortality in patients with severe aortic stenosis undergoing TAVI. |
id |
AMB-1_b50713ccff108ad78f7135f9d4580350 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302016000100032 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVIaortic valve stenosisprosthetic heart valveshemodynamicsSUMMARY Introduction: the EuroSCORE II and STS are the most used scores for surgical risk stratification and indication of transcatheter aortic valve implantation (TAVI). However, its role as a tool for mortality prediction in patients undergoing TAVI is still unclear. Objective: to evaluate the performance of the EuroSCORE II and STS as predictors of in-hospital and 30-day mortality in patients undergoing TAVI. Methods: we included 59 symptomatic patients with severe aortic stenosis that underwent TAVI between 2010 and 2014. The variables were analyzed using Student's t-test and Fisher's exact test and the discriminative power was evaluated using receiver operating characteristic curve (ROC) and area under the curve (AUC) with a 95% confidence interval. Results: mean age was 81±7.3 years, 42.3% men. The mean EuroSCORE II was 7.6±7.3 % and STS was 20.7±10.3%. Transfemoral procedure was performed in 88.13%, transapical in 3.38% and transaortic in 8.47%. In-hospital mortality was 10.1% and 30-day mortality was 13.5%. Patients who died had EuroSCORE II and STS higher than the survivors (33.7±16.7vs. 18.6±7.3% p=0,0001 for STS and 13.9±16.1 vs. 4.8±3.8% p=0.0007 for EuroSCORE II). The STS showed an AUC of 0.81 and the EuroSCORE II of 0.77 and there were no differences in the discrimination ability using ROC curves (p=0.72). Conclusion: in this cohort, the STS and EuroSCORE II were predictors of in-hospital and 30-days mortality in patients with severe aortic stenosis undergoing TAVI.Associação Médica Brasileira2016-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016000100032Revista da Associação Médica Brasileira v.62 n.1 2016reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.62.01.32info:eu-repo/semantics/openAccessRosa,Vitor Emer EgyptoLopes,Antonio Sergio de Santis AndradeAccorsi,Tarso Augusto DuenhasFernandes,João Ricardo CordeiroSpina,Guilherme SobreiraSampaio,Roney OrismarPaixão,Milena RibeiroPomerantzeff,Pablo MariaLemos Neto,Pedro AlvesTarasoutchi,Flávioeng2016-03-18T00:00:00Zoai:scielo:S0104-42302016000100032Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2016-03-18T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
title |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
spellingShingle |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI Rosa,Vitor Emer Egypto aortic valve stenosis prosthetic heart valves hemodynamics |
title_short |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
title_full |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
title_fullStr |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
title_full_unstemmed |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
title_sort |
EuroSCORE II and STS as mortality predictors in patients undergoing TAVI |
author |
Rosa,Vitor Emer Egypto |
author_facet |
Rosa,Vitor Emer Egypto Lopes,Antonio Sergio de Santis Andrade Accorsi,Tarso Augusto Duenhas Fernandes,João Ricardo Cordeiro Spina,Guilherme Sobreira Sampaio,Roney Orismar Paixão,Milena Ribeiro Pomerantzeff,Pablo Maria Lemos Neto,Pedro Alves Tarasoutchi,Flávio |
author_role |
author |
author2 |
Lopes,Antonio Sergio de Santis Andrade Accorsi,Tarso Augusto Duenhas Fernandes,João Ricardo Cordeiro Spina,Guilherme Sobreira Sampaio,Roney Orismar Paixão,Milena Ribeiro Pomerantzeff,Pablo Maria Lemos Neto,Pedro Alves Tarasoutchi,Flávio |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Rosa,Vitor Emer Egypto Lopes,Antonio Sergio de Santis Andrade Accorsi,Tarso Augusto Duenhas Fernandes,João Ricardo Cordeiro Spina,Guilherme Sobreira Sampaio,Roney Orismar Paixão,Milena Ribeiro Pomerantzeff,Pablo Maria Lemos Neto,Pedro Alves Tarasoutchi,Flávio |
dc.subject.por.fl_str_mv |
aortic valve stenosis prosthetic heart valves hemodynamics |
topic |
aortic valve stenosis prosthetic heart valves hemodynamics |
description |
SUMMARY Introduction: the EuroSCORE II and STS are the most used scores for surgical risk stratification and indication of transcatheter aortic valve implantation (TAVI). However, its role as a tool for mortality prediction in patients undergoing TAVI is still unclear. Objective: to evaluate the performance of the EuroSCORE II and STS as predictors of in-hospital and 30-day mortality in patients undergoing TAVI. Methods: we included 59 symptomatic patients with severe aortic stenosis that underwent TAVI between 2010 and 2014. The variables were analyzed using Student's t-test and Fisher's exact test and the discriminative power was evaluated using receiver operating characteristic curve (ROC) and area under the curve (AUC) with a 95% confidence interval. Results: mean age was 81±7.3 years, 42.3% men. The mean EuroSCORE II was 7.6±7.3 % and STS was 20.7±10.3%. Transfemoral procedure was performed in 88.13%, transapical in 3.38% and transaortic in 8.47%. In-hospital mortality was 10.1% and 30-day mortality was 13.5%. Patients who died had EuroSCORE II and STS higher than the survivors (33.7±16.7vs. 18.6±7.3% p=0,0001 for STS and 13.9±16.1 vs. 4.8±3.8% p=0.0007 for EuroSCORE II). The STS showed an AUC of 0.81 and the EuroSCORE II of 0.77 and there were no differences in the discrimination ability using ROC curves (p=0.72). Conclusion: in this cohort, the STS and EuroSCORE II were predictors of in-hospital and 30-days mortality in patients with severe aortic stenosis undergoing TAVI. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016000100032 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302016000100032 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.62.01.32 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.62 n.1 2016 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212831612370944 |